Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Gawałko, M; Duncker, D; Manninger, M; van, der, Velden, RMJ; Hermans, ANL; Verhaert, DVM; Pison, L; Pisters, R; Hemels, M; Sultan, A; Steven, D; Gupta, D; Heidbuchel, H; Sohaib, A; Wijtvliet, P; Tieleman, R; Gruwez, H; Chun, J; Schmidt, B; Keaney, JJ; Müller, P; Lodziński, P; Svennberg, E; Hoekstra, O; Jansen, WPJ; Desteghe, L; de, Potter, T; Tomlinson, DR; Neubeck, L; Crijns, HJGM; Pluymaekers, NAHA; Hendriks, JM; Linz, D, , TeleCheck-AF, investigators.
The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences.
Europace. 2021; 23(7):1003-1015
Doi: 10.1093/europace/euab050
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Manninger-Wünscher Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- AIMS: TeleCheck-AF is a multicentre international project initiated to maintain care delivery for patients with atrial fibrillation (AF) during COVID-19 through teleconsultations supported by an on-demand photoplethysmography-based heart rate and rhythm monitoring app (FibriCheck®). We describe the characteristics, inclusion rates, and experiences from participating centres according the TeleCheck-AF infrastructure as well as characteristics and experiences from recruited patients. METHODS AND RESULTS: Three surveys exploring centre characteristics (n = 25), centre experiences (n = 23), and patient experiences (n = 826) were completed. Self-reported patient characteristics were obtained from the app. Most centres were academic (64%) and specialized public cardiology/district hospitals (36%). Majority of the centres had AF outpatient clinics (64%) and only 36% had AF ablation clinics. The time required to start patient inclusion and total number of included patients in the project was comparable for centres experienced (56%) or inexperienced in mHealth use. Within 28 weeks, 1930 AF patients were recruited, mainly for remote AF control (31% of patients) and AF ablation follow-up (42%). Average inclusion rate was highest during the lockdown restrictions and reached a steady state at a lower level after easing the restrictions (188 vs. 52 weekly recruited patients). Majority (>80%) of the centres reported no problems during the implementation of the TeleCheck-AF approach. Recruited patients [median age 64 (55-71), 62% male] agreed that the FibriCheck® app was easy to use (94%). CONCLUSION: Despite different health care settings and mobile health experiences, the TeleCheck-AF approach could be set up within an extremely short time and easily used in different European centres during COVID-19.
- Find related publications in this database (using NLM MeSH Indexing)
- Atrial Fibrillation - diagnosis, epidemiology, therapy
- COVID-19 - administration & dosage
- Communicable Disease Control - administration & dosage
- Female - administration & dosage
- Humans - administration & dosage
- Male - administration & dosage
- Middle Aged - administration & dosage
- Mobile Applications - administration & dosage
- Pandemics - administration & dosage
- Patient Outcome Assessment - administration & dosage
- SARS-CoV-2 - administration & dosage
- Find related publications in this database (Keywords)
- Atrial fibrillation
- eHealth
- mHealth
- Remote monitoring
- Telemedicine
- TeleCheck-AF
- COVID-19